USPSTF Must Include Link to Liver Disease in Recommendation on Screening for Diabetes Global Liver Institute (GLI) and many of the leaders of the liver, diabetes and obesity advocacy community have...
NASH News April 2021
read more
Global Liver Institute
Donna Cryer
Donna R. Cryer, JD is Founder, President and Chief Executive Officer of Global Liver Institute, the only patient-driven liver health nonprofit operating across the US, EU, and UK. GLI convenes the NASH, Liver Cancer and Pediatric and Rare Liver Disease Councils, as well as the Liver Action Network, collectively more than 200 organizations.
Getting the COVID-19 vaccine? Things to know if you have liver disease or are immunocompromised!
Whether you are waiting for your COVID-19 vaccine appointment or are fully vaccinated already, you might have many questions about what is next. Today, we have compiled a list of things you...
USPSTF Must Include Link to Liver Disease in Recommendation on Screening for Diabetes
(Washington, D.C., April 13, 2021) – Global Liver Institute (GLI) and many of the leaders of the liver, diabetes and obesity advocacy community have submitted a formal letter and comments to...
More Vaccines, Fewer Tests: Why COVID-19 Testing Remains Important
As COVID-19 vaccination programs are expanding in scale across the United States, it is easy to neglect the fact that effective containment of the pandemic requires not only mass vaccination to...
The Need to Support the Restart of Liver Disease Medical Research and Public Health Programs
POLICY PERSPECTIVE Over the years, federal research has responded by sparking significant breakthroughs and achievements like the cure for Hepatitis C. It’s clear that when federal agencies support...
NASH News March 2021 – Recognizing NASH Patient Advocacy
Recognizing NASH Patient Advocacy For many NASH patient advocates and leaders of patient advocacy organizations, the opening of the much anticipated NASH-TAG meeting in Deer Valley, Utah, the annual...
Failure to Protect the Most Vulnerable: COVID-19 Vaccine Safety and Efficacy Issues Loom Large for Transplant and Immunosuppressed Communities
Introduction The three COVID-19 vaccines authorized by the United States — Pfizer, Moderna, and, most recently, Johnson & Johnson — have been proven safe and effective in the general population....
Organ Transplant Recipients Must Be Prioritized for COVID-19 Vaccination
(Washington, D.C., March 17, 2021) – As vaccination efforts ramp up both in the U.S. and globally, solid organ transplant recipients remain unprioritized and unvaccinated. Transplant recipients are...
Global COVID-19 Vaccination Race: Who is Left Behind?
As we applaud breakthroughs in COVID-19 vaccine development across the globe, we are also hoping to see a fair and equitable vaccine allocation. Unsurprisingly, the distribution of vaccines is never...
Prioritize Liver Disease in Vaccine Distribution
POLICY PERSPECTIVE As the United States and the international community continue to tackle the COVID-19 health crisis, insufficient vaccine supply has made equitable allocation and distribution of...
Recent News
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver Health
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver HealthHepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you're likely familiar with the chronic health challenges...
Congress goes into recess in October while staff prepare for a potentially busy November lame-duck session – Liver Health Policy Update
Congress goes into recess in October while staff work behind the scenes to prepare for a potentially busy November lame-duck session Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the...
Cancer Care for the Underrepresented #Octoberis4Livers – Liver Cancer News
Cancer Care for the Underrepresented #Octoberis4Livers Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers...
Emerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver Disease News
Emerging Evidence in Liver Health: GLP-1, Pollution, and MoreDespite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies. Recent studies show promising interventions for early diagnosis and treatment, while also...
2025 ICD-10 Coding will include code for cholestatic pruritus – Pediatric & Rare Liver Diseases News
New changes in 2025 ICD-10 Coding includes a code for cholestatic pruritus Critical Path Global Impact Conference highlights collaborative progress The Critical Path Global Impact Conference brought together patient advocates, regulators, and...